Borderline Personality Disorder Clinical Trial
— MindIEOfficial title:
Mindfulness Approach for Adults Experiencing Borderline Personality Disorder; Supporting the Management of Intense and Fluctuating Emotions, a Feasibility Study
This study explores the feasibility of a mindfulness-based intervention for people with a diagnosis of borderline personality disorder.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | August 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - Are on the caseload of a United Kingdom National Health Service Assessment and Treatment Service in the recruitment area and have had contact with that service in the past three months - Have received the diagnosis of Borderline Personality Disorder from a suitably qualified health care professional, and continue to meet criteria for this diagnosis according to the SCID-II (Structured Clinical Interview for DSM Disorders Version II) at their screening assessment - Have sufficient English language speaking and comprehension abilities to access group discussions and hand-out materials - Have not previously engaged in a mindfulness-based intervention. As in other similar trials, a minimum dose has been operationally defined as having undertaken 50% or more of a mindfulness-based intervention delivered face-to-face by a suitably qualified health care professional - Are not currently receiving, nor have plans to receive any other form of psychological therapy during the course of the study Exclusion criteria: - Have psychosis - Misuse alcohol or drug to a level that requiring detox - Have a intellectual disability - Present a high level of risk requiring inpatient management at the time of their screening assessment |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | Sussex Partnership NHS Foundation Trust | Brighton | Sussex |
Lead Sponsor | Collaborator |
---|---|
Canterbury Christ Church University | Sussex Partnership NHS Foundation Trust |
United Kingdom,
Elliot R. (2012). Qualitative Methods for Studying Psychotherapy Change Processes. In: Thompson, A, & Harper D. (Eds.), Qualitative research methods in mental health and psychotherapy: An introduction for students and practitioners (pp. 69-81). Chichester, UK: Wiley-Blackwells
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Participant retention in percent | The number of participants who remain in the study at the post-intervention time point divided by the number of participants who are recruited into the study at baseline, expressed as a percentage | At post-intervention (i.e. 8 weeks after the start of the intervention). | No |
Secondary | Change from baseline at post-intervention in the Difficulties in the Emotion Regulation Scale (DERS) | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | Change from baseline at post-intervention in the Patient Health Questionnaire (PQH-9). | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | Change from baseline at post-intervention in the Generalized Anxiety Disorder Scale (GAD-7) | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | Change from baseline at post-intervention in the Five-Facet Mindfulness Questionnaire (FFMQ) | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | United Kingdom National Health Service Friends and Family Test (FFT). | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | Elliot et al.'s (2001) Change Interview. | Post-intervention (i.e. 8 weeks after the start of the intervention) | No | |
Secondary | Recruitment rate | The number of participants recruited into the study at baseline divided by the time taken to recruit these participants, measured from the date at which recruitment opened. | Baseline | No |
Secondary | Qualitative feedback from participants on intervention acceptability in response to questions 6 and 7 of Elliot et al.'s (2001) Change Interview | Post-intervention (i.e. 8 weeks after the start of the intervention) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |